Standardization of autoimmune testing – is it feasible?-Reference-Cited by-同舟云学术

Standardization of autoimmune testing – is it feasible?

Published:2018-04-07 Issue:10 Volume:56 Page:1734-1742
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Monogioudi Evanthia¹^ORCID,Martos Gustavo²,Hutu Dana Petronela²,Schimmel Heinz²,Meroni Pier Luigi³,Sheldon Joanna⁴,Zegers Ingrid²

Affiliation:

1. European Commission – Joint Research Centre, Directorate F , Retieseweg 111 , 02440-Geel , Belgium , Phone: +32-14-571906

2. European Commission – Joint Research Centre, Directorate F , Geel , Belgium

3. University of Milan , IRCCS Instituto Auxologico Italiano , Milan , Italy

4. St. George’s Hospital, Protein Reference Unit , London , UK

Abstract

Abstract Correct measurement of autoantibodies is essential for the diagnosis of autoimmune diseases. However, due to the variability of autoantibody results and the heterogeneity of testing, wrong diagnosis is a reality. For this and more reasons, harmonization of testing is of the outmost importance. In this review we have summarized the factors contributing to this variability. The ways with which the working group on harmonization of autoantibody testing of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has been trying to tackle the issue with the production and correct use of certified reference materials (CRMs), is discussed. Finally the advantages and the limitations of the use of CRMs are presented.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2017-1077/pdf

Reference43 articles.

1. Mackay IR, Burnet FM. Autoimmune diseases, pathogenesis, chemistry and therapy. Springfield, IL: John Wiley & Sons, Inc., 1963.

2. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 1993;14:426–30.

3. Pillai S, Mattoo H, Cariappa A. B cells and autoimmunity. Curr Opin Immunol 2011;23:721–31.

4. Giltiay NV, Chappell CF, Clark EA. B-cell selection and the development of autoantibodies. Arthritis Res Ther 2012;14(Suppl 4):S1.

5. Mackay IR. Tolerance and autoimmunity. West J Med 2001;174:118–23.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Le raccomandazioni SIPMeL per l'accreditamento ISO del monitoraggio di validità dei risultati degli esami;La Rivista Italiana della Medicina di Laboratorio;2024-09

2. Toward harmonized interpretation of anticardiolipin and anti–β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies;Journal of Thrombosis and Haemostasis;2024-08

3. Plasmonic biosensors: Towards fully operative detection platforms for biomedical application and its potential for the diagnosis of autoimmune diseases;TrAC Trends in Analytical Chemistry;2024-07

4. From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice;Autoimmunity Reviews;2024-05

5. The harmonization issue in laboratory medicine: the commitment of CCLM;Clinical Chemistry and Laboratory Medicine (CCLM);2022-11-16